proposed a model for the dynamics of diseases of the central nervous system caused by prions. It is based on the protein-only hypothesis (Prusiner et al., 1981, Proc. Natl. Acad. Sci. ;.S.A. 78, 6675}6679), which assumes that infection can be spread by particular proteins (prions) that can exist in two forms that share the same sequence, but have a di!erent structure. The normal form is harmless, while the infectious isoform of the prion protein catalyses a transconformation from the native isoform to itself within a specialized compartment of the brain cells. This paper systematically explores the model behavior with the aim of quantifying the fundamental parameters characterizing the dynamics of prion infection. To this end we use data from the literature to "x orders of magnitude for the rates of synthesis and degradation of the native form of prion protein and for the shape of the autocatalytic function. The dynamical behavior is classi"ed with respect to two unknown parameters (bifurcation analysis): the rate of spontaneous transconformation and the rate of output of the infectious isoform from the specialized compartment. We thus "nd that the bistability properties evidenced by Laurent are con"ned to a certain range of parameters and that permanent oscillations of the two isoforms concentrations are possible. The bifurcation analysis allows us to estimate approximate ranges for the values of the two unknown parameters and consequently to derive incubation times and compare them with actual data for hamster. Also, our study predicts that the output rate of the infectious isoform is relatively insensitive to variations of model parameters.
Introduction
Prion diseases (Weissmann, 1994) were "rst diagnosed in the middle of the 18th century, with the discovery of a new kind of disease in sheep: infected animals presented excitability, itching and ataxia due to a degeneracy of the central nervous system which, in the long run, led to paralysis and death. The disease was named scrapie from the behavior of animals, scraping themselves to relieve itching.
Several diseases, which are all supposed to share a mechanism involving prions, are recognized today. They a!ect humans, sheep, cows (bovine spongiform encephalopathy better known as BSE), mice and many other species and can be sporadic, genetic or infectious. Human prion diseases include Creutzfeld}Jacob disease (CJD), Kuru (Gajdusek, 1977) , Gerstmann} StraK ussler}Scheinker syndrome (GSS) and fatal familial insomnia (FFI) . The main characteristics of prion diseases are (Caughey & Chesebro, 1997) :
E a long incubation period (up to 35 years for humans); E a degeneracy of central nervous system leading to death; E neuropathological changes such as neurons death and spongiosis of brain (the prion diseases are also known as transmissible spongiform encephalopathies); E the absence of immunological response; and E intra-and inter-speci"c transmissibility (Aguzzi, 1996; Bruce et al., 1997; Hill et al., 1997) .
In 1981 Stanley Prusiner showed that the scrapie agent contained a protein (Prusiner et al., 1981; Prusiner, 1982) . This &&proteinaceous infectious particle'' was named &&prion'' to distinguish it from conventional transmissible agents such as viruses or bacteria. Prusiner strongly argued that the nature of this agent was one of unexpected properties: it may consist of protein only because no nucleic acid related to the disease has been found up to now (Prusiner, 1991) . The component of the prion appears to be an isomeric form of a cellular protein called PrP (prion protein, Dolton et al., 1982; BuK eler et al., 1993) . The normal form of the protein, PrP (cellular) can be found mainly in neuronal cells of either normal or infected individuals, whereas the pathogenic form PrP1 (scrapie) is only found in the central and/or peripheral nervous systems of infected animals, and is a protease-resistant form of the PrP (Kocisko et al., 1994) (the sequences of the two proteins are the same, but the species di!er in their secondary structure). The abnormal form PrP1 associated to BSE and related CJD is not easily degradable (the degradation time constant is not known, but is <24 hr according to Borchelt et al., 1990) , is exported to the cell surface and can aggregate outside the cell where it might be responsible for the formation of PrP-amyloid plaques in the brain of infected animals (Dolton et al., 1982; Bendheim et al., 1984) .
The unusual properties of prions gave rise to a multitude of hypotheses about their nature and ability to spread within the brain of infected individuals. The most credited are the following (Weissmann, 1994 ):
E the virus hypothesis considers that a classical viral nucleic acid does exist but has not been isolated yet; E in the virino hypothesis, the pathogenic agent consists of a nucleic acid encoding itself (it does not encode any protein), recruiting the host PrP and changing it into PrP1 so as to build a proteinic &&coat''. The nucleic acid could not be isolated because of the resistance of this proteinic coat; E the protein-only hypothesis, pioneered by Gri$th (1967) and vigorously supported by the work of Prusiner, is the most commonly accepted and suggests that PrP1 derives from PrP thanks to an autocatalytic process: the infectious form PrP1 can catalyse a transconformation PrP PPrP1 . The mechanism through which this occurs might follow a &&refolding model'' (Prusiner, 1991; Weissmann, 1995) , in which PrP changes its conformation in the presence of one PrP1 protein acting as a chaperoning protein, or a &&nucleation model'' (Jarret & Lansbury, 1993; Kocisko et al., 1995; Weissmann, 1995) , in which transconformation occurs when PrP binds to a nucleus of PrP1 .
Relevant mathematical models describing the underlying biochemistry of prion diseases and based on the protein-only hypothesis have been proposed by Kacser & Small (1996) , Eigen (1996) and Laurent (1996a Laurent ( ,b, 1998 and more recently by Payne & Krakauer (1998) and Nowak et al. (1998) . Kacser and Small and Laurent showed that a model system based on the autocatalytic process of the protein-only hypothesis exhibits properties of bistability and can exist in two alternative stable steady states. One of them, characterized by its low PrP1 concentration, can be considered as the state of cells in the brain of a non-infected individual. The other one, because of its high PrP1 concentration, is thought to be a pathogenic steady state. Changes in the kinetic parameters and/or inoculation of a certain amount of PrP1 can switch the system from the healthy steady state to the pathogenic steady state. This transition is supposed to be irreversible. Therefore, these models might provide 284 E. PORCHER AND M. GATTO a simple explanation for the occurrence of prion disease in a single organism by describing the dynamics of prion proteins within a cell (or within the brain of an animal, considered as a homogeneous medium). Payne & Krakauer's (1998) model tries to explain long incubation periods of TSE's by assuming the existence of a bottleneck in the natural protein pathways within the cell. It considers intracellular and surface-bound concentrations of both isoforms and is characterized by bistability too. Nowak et al. (1998) assume nucleation as the basic mechanism [see Eigen (1996) for a thorough discussion of the di!erent mechanisms underlying the protein-only hypothesis], from which they derive a model for each cell with three state variables: abundance of PrP monomers, abundance of PrP1 aggregates of monomers and total number of monomers bound in PrP1 aggregates. The model does not have a bistable behavior and is subsequently used as a fundamental unit in simulation model which considers a two-dimensional array of cells. The authors also present a more sophisticated model for a single cell ("ve state variables) where PrP1 aggregation requires a nucleation seed of a certain minimum size. This model instead has bistability properties. In fact, it assumes that all aggregates of monomers below a critical size are unstable and rapidly fall into pieces which convert back to PrP . In mathematical terms, there can be three equilibria for the "ve variables model:
(1) No monomers or polymers are present.
(2) Monomers are present, but there are no polymers.
(3) Both monomers and polymers are present. Nowak et al. (1998) show (by computing basic reproductive ratios) that equilibria (1) and (3) are stable, whereas equilibrium (2) is unstable. These models correspond to di!erent conceptual mechanisms and their stated goal is to explain prion protein dynamics from a qualitative viewpoint. However, some quanti"cation is required to check whether these models can be accepted as a possible paradigm of reality: some of these mechanisms might not work in reality because they require parameter values that are unrealistic. Unfortunately, very few attempts have been made to quantify the kinetic parameters of prion infection. The criteria according to which some authors chose numerical values of basic coe$cients, such as rates of protein synthesis and degradation, were unclear. As a matter of fact, only the three-dimensional nucleation model by Nowak et al. (1998) has been subjected to a quantitative analysis (Masel et al., 1999) . In this paper, the authors use experimental data on the initial exponential growth of the disease infectivity to estimate some key parameters of the nucleation model. As their results are quite consistent with published experimental observations, they conclude that nucleation cannot be ruled out on dynamic grounds.
The dynamic behavior of the above models can greatly vary in response to di!erent parameter values. However, this aspect of the problem has not been explored su$ciently (or at all). Indeed, we think that it would be very useful to conduct studies that evidence those parameter values at which the proposed model dynamics undergo qualitative changes. In mathematical terms, these are called bifurcation analyses. Through these analyses the role played by the di!erent parameters in determining, e.g., bistability properties could be clari"ed. This paper is a partial response to the needs just outlined. In fact, our goal is to quantify the parameters and explore the dynamic behavior of bistable models of prion infection. As there is no conclusive evidence for the refolding or the nucleation mechanism (Wille et al., 1996) , we stick to a simple and rather general model, like the one proposed by Laurent (1996a,b) . With reference to this model we have collected the scant available information (data on Syrian Hamsters are used) to "x orders of magnitude for some parameters: the rates of synthesis and degradation of the native form PrP and the parameters de"ning the autocatalytic function. Then we proceed to a complete bifurcation analysis with respect to those parameters that are most uncertain, namely the coe$cients regulating the spontaneous formation of PrP1 from PrP in endosomes and the PrP1 output from endosomes. The analysis reveals that the bistability properties of the system are con"ned to a possibly narrow range of values for the uncertain parameters and that the model can be Metabolism of prion proteins according to the scheme of Laurent's model. The messenger PrP is directly transcribed into the normal isoform PrP (step 1) while the pathogenic form PrP1 originates from the PrP , thanks to an autocatalytic mechanism (step 3). PrP is also subject to degradation (step 2). PrP1 is exported to the cell surface and can aggregate outside the cell where it might be responsible for the formation of PrP-amyloid plaques (step 4).
characterized by cyclic #uctuations, a feature which was not evidenced by the previous authors. Using the estimated values of the coe$cients of the prion dynamic model, we then proceed to an estimation of both incubation time and the amount of PrP1 that is produced in endocytic compartments and is exported to the cell surface and outside the cell.
Review of Laurent:s Models of Scrapie-related Biochemistry
Here we review the models developed by Laurent (1998) to describe prion dynamics. The "rst model he proposed corresponds to the scheme of Fig. 1 . Therefore, the dynamics of the concentration of PrP and PrP1 is given by the equations
where t is the time, [PrPA] and [PrP1A] the concentrations of the di!erent species within a specialized cell compartment (most likely, endocytosis vesicles) and G the rate of step i.
Step 1 (PrP synthesis) is considered as a zero-order kinetic ( "k , positive constant), because of the constant level of the PrP messenger during a Scrapie infection (Borchelt et al., 1990; Oesch et al., 1995) , whereas steps 2 (degradation of PrP ) and 4 (output of PrP1 from endosomes) are "rst order kinetics ( "k [PrPA]) and " k [PrP1A], with k and k being positive constants. The autocatalytic step 3 is a nonlinear process and, although the mechanism of autocatalysis is unknown, the rate of formation of PrP1 can be described by the following phenomenological equation:
where a, r, n and c are positive constants and r, n'1. The rationale behind this equation is that there is a rate a[PrPA] of spontaneous formation of PrP1 from PrP which can be greatly accelerated (up to a factor r) by the presence of PrP1 . The parameters c and n de"ne the threshold concentration beyond which autocatalysis is e!ective and the steepness of the transition across the threshold. Though the parameters of this equation are purely phenomenological, there are some constraints on their numerical values: a, the coe$cient of spontaneous formation of PrP1 from PrP is much smaller (Laurent, 1996b) than the degradation coe$cient k , while the acceleration factor r has to be much bigger than unity for autocatalysis to be meaningful. In the case of certain mutations of the PrP gene, a can be increased by orders of magnitude (Laurent & Johannin, 1997) . Given all these kinetics, we can write the di!erential equations describing the evolution of the concentration of PrP and PrP1 over time:
Laurent studied the steady states of the system, characterized by constant values of PrP and PrP1 concentrations, and found that, depending on the turnover rate of PrP , the system can (1), (2) Laurent' s model when the system exhibits properties of bistability. The state of the system can be in either a normal equilibrium (characterized by a low PrP1 concentration) or a pathogenic equilibrium (characterized by a high PrP1 concentration). The basins are separated by the stable manifold of the saddle (separatrix). During an infection, the separatrix acts as a threshold: the disease cannot develop unless the increase of PrP1 concentration drives the system from the normal equilibrium beyond this threshold and into the basin of attraction of the pathogenic equilibrium.
possess one or two stable equilibria: a normal one with low PrP1 concentration and a pathogenic one with high PrP1 concentration. In fact, the null isoclines d[PrPA]/dt"0 and d[PrP1A]/dt"0 are two curves, respectively, given by the equations
The shape of the isoclines in the positive quadrant is portrayed in Fig. 2 . There is generically an odd number of intersections (steady states) between the two curves, although, with the range of parameters used by Laurent, there are no more than three. When this is the case (isoclines represented by solid lines in Fig. 2 ) the intermediate equilibrium is a saddle, namely a steady state attracting along a certain direction and repelling along another direction, while the other intersections de"ne the normal and the pathogenic equilibria. From these results, Laurent proposed two di!erent explanations for the occurrence of infectious or sporadic prion diseases:
1. The development of the disease after a contamination by PrP1 depends on the added quantities of PrP1 in the cell (or in the brain). In fact, as shown in Fig. 3 , the phase plane ([PrPA], [PrP1A] ) is partitioned by the separatrix associated with the saddle equilibrium into two regions, which correspond to the basins of attraction of two stable equilibria. The contamination of a cell in a normal state will not induce the disease as long as the state of the system is not kicked into the basin of attraction of the abnormal equilibrium. But if an inoculum of PrP1 brings the state of the system beyond a threshold, which is represented by the separatrix, the disease will develop.
2. As the bistability properties depend on the turnover rate of PrP (as shown in Fig. 2 where
dashed lines correspond to the isocline d[PrPA]/dt"0 for high and low turnover), the occurrence of sporadic diseases could be due to a modi"cation of this turnover rate, namely to an increase of k or a decrease of k . This change in PrP dynamics would make the system shift from bistability to pathogenic monostability, and &&the very slow accumulation of the abnormal form of the protein in the brain could in fact be the consequence and not the cause of the disorders'' (Laurent, 1996b) .
Considering that the biochemistry of the autocatalytic step is not well known and is described in a phenomenological way, alternative nonlinear autocatalytic equations may be used to model the conversion of PrP and PrP1 . Another model by Laurent (1998) is in fact based on the same scheme as the "rst one, but di!ers in the way the rate of formation of PrP1 from PrP is described:
with k QNMLR , k A?J and K + being positive constants. The spontaneous rate of formation of PrP1 is a "rst-order kinetic while autocatalysis is now additive and corresponds to the nonlinear term. The rationale behind this latter term is that PrP acts as a substrate and the dimeric form of the scrapie isoform acts as a catalyst. Another functional form was used by Kacser & Small (1996) , whose model has the further hypothesis that PrP1 does not originate directly from PrP , but from an intermediately species of PrP, which has not been experimentally evidenced yet. The study of this further model by Laurent (1998) shows that the system exhibits bistability properties that are similar to those already evidenced: the protein concentrations can be in either a normal or a pathogenic equilibrium. In other words, the second model does not possess any new dynamical property. For this reason, since the biochemistry of autocatalysis is not known in such a detail as to make us incline towards a particular equation, we will from now on concentrate our attention on the study of eqns (1) and (2).
Bifurcation Analysis
In this section, the dynamical system described by eqns (1) and (2) will be subjected to a bifurcation analysis (Kuznetsov, 1995) , namely to a mathematical study that points out for which parameter values the model dynamics undergoes qualitative changes. To simplify notation, we will from now on set X" [PrPA] and >" [PrP1A] . The model is therefore described by the equations:
Model (5), (6) is identi"ed by seven parameters, the actual values of which determine the dynamical behavior of the system. Despite the simplicity of the model a bifurcation analysis with respect to all of them is practically impossible. Therefore, we try to improve on past approaches by exploiting the existing experimental evidence to attribute reasonable values (or ranges of values) to some parameters and thus restrict the bifurcation analysis to a few of them.
Data concerning protein concentration in the brain of healthy or infected hamsters are given by Meyer et al. (1986) , Prusiner et al. (1990) and Prusiner (1991 , Table 1 ). Another information we may use is the estimation of the coe$cient of degradation of PrP , given by Borchelt et al. (1990) : k "0.13 hr\. From this value and the concentration of PrP in the brain of normal hamsters, we derive an estimation of the rate of synthesis of PrP (k ). In fact, in the brain of a non-infected animal, we may consider that >+0 and the dynamics of prion is simply given by
At equilibrium we thus have [PrPA] CO "k /k . As 1 g g\([PrPA] CO (5 g g\, we obtain a range of values for k : 0.13 g g\ hr\(k (0.65 g g\ hr\. We choose k "0.5 g g\ hr\ as a reference value for the bifurcation analysis. It should be remarked that this is not a limitation because the system can be rescaled with respect to k by taking X/k and >/k as new state variables. Therefore, all the bifurcation diagrams we will obtain can be simply referred to other values of k by suitable rescaling. The use of the available data on the concentration of PrP1 in infected animals is more critical. In fact, the concentration of the abnormal form of PrP in the brain of an infected hamster (5 g g\(>(10 g g\) is the "gure found at the onset of the disease, i.e. approximately 70 days after inoculation. At that time the disease has spread to a large part of the brain tissues. We have thus assumed that this "gure is an approximate indicator of PrP1 local concentration at equilibrium. This concentration may underestimate the cellular concentration used in our model, since it has been measured in brain homogenates that include also uninfected parts of the brain. On the other hand, the concentration of PrP1 in brain homogenates also accounts for extracellular aggregated PrP1 , which might counterbalance the previous underestimation. We can thus suppose that the value of 5}10 g g\ gives a good order of magnitude for the local cellular concentration of PrP1 . In this sense, it can be used to determine ranges for parameters c and n, which de"ne the threshold concentration of PrP1 for autocatalysis to be e!ective. More precisely, let f (>)"(1#rc>L)/ (1#c> L) be the factor that multiplies the rate of spontaneous conversion from PrP to PrP1 . This autocatalytic term corresponds to a sigmoid curve, whose in#ection point is > G " L ((n!1)/c(n#1) and which saturates to r for large values of >. Therefore, f ( ) ) is practically equal to unity for concentrations much smaller than > G , whereas it practically equals r for concentrations much higher than > G . The exponent n determines the rapidity of transition from no autocatalysis to full autocatalysis * larger n corresponds to a steeper f ( ) ) at > G . It is reasonable to assume that within the range of [PrP1A] (5 g g\(>(10 g g\) the factor f ( ) ) should be large enough for an e$cient autocatalysis to take place, but should not be saturated, otherwise the dynamics would become linear and the model would not be e!ective in describing the disease insurgence. Therefore, we will set a lower (2 g g\) and an upper bound (8 g g\) for the value of the in#ection point and conduct our analysis in correspondence to these two values. By setting > G , we constrain c to depend on n as follows:
Up to now, we have eliminated three degrees of freedom and are left with four parameters with respect to which the bifurcation analysis can be performed: the exponent n, the saturation level r, the spontaneous conversion coe$cient a and the PrP1 output coe$cient k . We have decided to concentrate our attention on a and k because of their biological importance. Therefore, we have chosen to run a bifurcation analysis in the parameter plane (k , a) for a few selected values of n and r. The range of n is assumed to be 2}6 and that for r to be 4}400 [Laurent (1996a) used n"4 and r"40] . The analysis will show that, for any r and n, the bistability properties of the prion system are con"ned to a range of values of k and a.
The bifurcation curves presented in this section have been computed by means of LOCBIF, a program implementing a powerful continuation technique for bifurcation analysis (Khibnik et al., 1993) . Figure 4 (a) provides an idea of the kind of bifurcation diagram which characterizes the model. It corresponds to some &&typical'' values for the parameters: in#ection point" 2 g g\, n"4, r"40. We have chosen these values, because in this way we obtain a reference diagram which includes all the possible bifurcations for the model we are considering. We can thus draw comparisons between that diagram Fig. 4(a) Fig. 4(a) and the ones plotted with di!erent values of > G , n and r. Figure 4 (a) is actually a simpli"ed version of the bifurcation diagram, because some bifurcation curves are so close that they have been consolidated. For this reason Fig. 4(b) shows a magni"cation of the window evidenced in Fig.  4(a) Fig. 4 (a) because they are very small, are shown in the enlargement. Each region corresponds to a particular set of invariants (equilibria and cycles) speci"ed in the caption to Fig. 4 . In region [1], characterized by low values of both a and k , the system exhibits properties of bistability, with a normal and a pathogenic equilibrium both being stable. In region [2], characterized by high a and low k the pathogenic equilibrium is the only steady state, because the saddle and the normal equilibrium have vanished via a fold bifurcation. In region [3] , characterized by low a and high k , only the normal equilibrium exists, because the saddle and the pathogenic equilibrium have vanished via another fold bifurcation. In region [4] , characterized by intermediate values of both the rate of PrP1 output from endosome and the rate of spontaneous conversion, a kind of dynamics not evidenced by the previous studies appears: there are no stable ) and the spontaneous conversion coe$cient (a). The "gure shows the in#uence of the in#ection point > G , the saturation level r and the exponent n on the existence and shape of the bifurcation curves. Dashed curves identify Hopf bifurcations while solid lines correspond to fold bifurcations of equilibria. The rates of synthesis (k ) and degradation (k ) of PrP are set to their reference values. (a)}(f) correspond to an in#ection point of 2 g g\, while for (g)}(i) the in#ection point is 8 g g\. The value of c depends on n as shown in eqn (7). When the in#ection point is 8 g g\, there is no bifurcation for n"2, r"4.
equilibria, but there is a limit cycle and therefore the concentration of prion proteins undergoes cyclic #uctuations. The cycle is born via a supercritical Hopf bifurcation from either a normal or a pathogenic equilibrium. Figure 5 shows the in#uence of the parameters determining the intensity of autocatalysis (namely the in#ection point > G , the saturation level r and the exponent n) on the existence and shape of bifurcation curves. Although values of a and k are not known, upper bounds for both parameters have been established. As a is known to be much smaller than k "0.13 hr\, this value has been used as an upper bound. As for k , its upper bound is suitably adjusted so that all bifurcation curves within the range of a are included. A "rst remark that emerges from analysing Fig. 5 is that a lower value of the in#ection point [ Fig. 5 (a)}(f)] corresponds to a greater variety of the bifurcation diagrams. In particular, for small values of r and n (r"4 and n"2), there is no bifurcation, because there exists only one equilibrium. This equilibrium may be de"ned as normal for high values of PrP1 output rate or small values of the spontaneous rate of PrP1 formation and pathogenic for low k or high a. On the contrary, for strong (r"400) and highly nonlinear (n"6) autocatalysis, both oscillations and bistability of QUANTIFYING PRION INFECTION DYNAMICS 291 equilibria are possible. Increasing r from 4 to 400 brings about oscillations, while increasing n from 2 to 6 has the e!ect of augmenting the parameter region where bistability occurs. When we assume a higher in#ection point [8 g g\, Fig. 5(g)}(i) ], we see that no oscillations are possible. For low values of the strength of autocatalysis (r"4) only high n yields a (small) bistability region. For r"400, bistability is restricted to a small area in the parameter space for low n, yields a (small) bistability region. For r"400, bistability is restricted to a small area in the parameter space for low n, whereas n"6 corresponds to a wider area of bistability.
Discussion
In this paper, we have explored and quanti"ed the dynamics of prion proteins within the brain of an individual by means of a mathematical model [eqns (5) and (6)] developed by Laurent. This author let the turnover of PrP vary for a given set of the other parameters and investigated the response of the model to this variation. Contrary to what he did, we have estimated k and k from the literature and have instead studied the in#u-ence of the parameters de"ning autocatalysis and exit of the scrapie isoform from a cellular specialized compartment. To this end, we have run a bifurcation analysis of the model with respect to the two biochemical parameters (the spontaneous conversion coe$cient and the PrP1 output coe$cient, a and k ) that seem to be most critical, as there is very little experimental information on their ranges. We have shown that the bistability properties evidenced by Laurent and Kacser and Small are often con"ned to a rather small range of values for these two parameters. This seems to point out that of the two mechanisms postulated by Laurent for the insurgence of the disease (contamination from PrP1 in a bistable system or modi"cation of some structural parameters that make the system shift to pathogenic monostability) it is the latter that seems to be most likely for scrapie-infected hamsters. More precisely, a reduction of the PrP1 output rate or an increase in the rate of spontaneous formation of PrP1 might bring the system from region [3] (or [1] ) to region [2] and, as a result, trigger the development of the disease. While the in#uence of the rate of spontaneous formation of PrP1 was predictable (the more PrP1 is synthesized, the less probable is the existence of a normal equilibrium), the e!ect of a small rate of output of the scrapie isoform from a brain cell may appear somehow surprising. The rationale behind this e!ect is as follows: lower values of k imply a higher concentration of PrP1 and this, in turn, greatly accelerates autocatalysis, thus creating pathogenic monostability. Our bifurcation diagram has also revealed the existence of cyclic dynamics, which were not evidenced by previous analyses. It remains to be seen whether they can play an important role in practice, because the size of the cycles is rather small (this has been shown by extensive simulation) and oscillations can be found only for particular values of a and k . The experimental con"rmation of the existence of oscillations would certainly be hindered by di$culty in collecting the relevant data. Also, it is quite possible that the existence of oscillations depends on the model we have chosen, which is purely phenomenological.
It is worth noticing that from Fig. 5 one can infer that either mechanism of disease insurgence can operate only for values of k (0.5 hr\, because for greater values no catastrophic bifurcation curve is crossed by varying a or k . Actually, we can further restrict the range of values for k because it can be actually shown that the pathogenic equilibrium (high PrP1 concentration) is really distinct from the normal one (low PrP1 concentration) in the lower part of the regions of bistability. Thus, we can very roughly set an upper bound of 0.1 hr\ for the rate of PrP1 output from the specialized compartment. We thus see how the bifurcation analysis provides a way to approximately estimate a basically unknown parameter.
A fundamental problem that can be addressed by using the parameter values so far estimated is that of incubation times, which are known to be quite long (from a few days to many years for human TSEs). Laurent (1996b) found that the shift to the pathogenic equilibrium is a very rapid step (the order of seconds). His result, however, is clearly due to the inappropriate choice of parameter values. We have therefore estimated the time required to go to a pathogenic state with our set of parameters. The infection has been 292 E. PORCHER AND M. GATTO (Prusiner, 1991; =eissmann, 1994) Note: We simulate an infection either through an inoculum or an increase of the spontaneous conversion rate a(;2). Numbers in bold correspond to the latter mechanism. We set k "0.05 hr\, while values for a were chosen so as to obtain bistability. k and k were set to their reference values.
simulated according to the two di!erent insurgence mechanisms as follows: (1) given the concentrations of PrP and PrP1 at the normal equilibrium, we have increased the initial concentration of PrP1 so as to exceed the threshold (given by the separatrix, shown in Fig. 3 ) by 10% and then we have calculated the time required for the system to go to the pathogenic equilibrium ($10%); and (2) given the concentrations of PrP and PrP1 at the normal equilibrium for a certain value of a, we have doubled a and then we have calculated the time required for the system to go to the pathogenic equilibrium ($10%) corresponding to the new value of a. The results, provided in Table 2 , show that this time, although on a correct scale of days instead of seconds, is much shorter than the measured incubation period of scrapie in hamsters. However, it should be remarked that reaching the pathogenic equilibrium at the cellular level does not mean that the "rst disorders associated with prion diseases will appear immediately. In fact, incubation times are measured as the time elapsed between inoculum of infected brain and development of clinical signs of scrapie, but the accumulation of PrP1 begins much earlier. As reported by De Armond et al. (1992) , PrP1 is "rst detected in the thalamus of Syrian hamsters about 15 days after inoculation. It then spreads to septum, neocortex and "nally caudate nucleus after c. 60 days. At this time the "rst clinical signs of scrapie begin to appear. We do not know if the neurological dysfunctions are due to the accumulation of PrP1 in the brain or its aggregation into amyloid "brils or the lack, in the long run, of functional PrP [see the article by Brown et al. (1997) on the role of PrP in regulating copper in cell membranes]. Although the period between the time when Laurent's model reaches the socalled pathogenic equilibrium and the "rst observation of actual pathological changes is quite long, the predictions of Table 2 are not so unrealistic, if one considers that the model is intended to describe the cellular level or a brain considered as a homogeneous medium (which is not in reality).
If we formulate the hypothesis that the disease becomes full-#edged because of the e!ect of neurotoxic aggregates, we can use the model to estimate the amount of PrP Sc that is exported to the cell surface and might, at least in part, aggregate outside the cell. output of PrP1 (k [PrP1A] ) at equilibrium varies with k itself. It is interesting to remark that the rate is remarkably constant up to values of k quite close to the fold bifurcation. If we let parameters other than k vary, the rate of aggregation changes accordingly but the range is not very wide: between 0.2 and 0.5 g g\ hr\. If there were an experimental way to distinguish between intracellular and extracellular PrP1 , this prediction might be tested. Unfortunately, we have not been able to "nd data that could be usefully compared with our guess.
Concluding Remarks
The model of prion infection we have analysed is extremely crude, as it neglects a precise description of underlying biochemistry and considers only the cellular level or the brain as a homogeneous medium. There is no doubt that more realistic models could be utilized to explore the dynamics of prion disease in greater detail. In particular, including spatial e!ect seems of the greatest importance. However, even if we restrict our attention to the central nervous system and neglect the problem of di!usion from peripheral tissues to the brain, this would require an explicit description of both axonal transport and di!usion through the extracellular compartment. Unfortunately, no quanti"cation is possible, as of now, for the transmission rate from cell to cell. Also, it is not clear up to now whether amyloid aggregates in the extracellular space can be instrumental in spreading infection (Wille et al., 1996) . Therefore, building realistic spatial models is quite problematic at the moment. An attempt has been made through the simulation of a cellular array by Nowak et al. (1998) , but more work is necessary to obtain convincing models. Indeed, it is the very simplicity of Laurent's model that has allowed us to roughly estimate some basic and previously unknown parameters of the infection dynamics. As more and more data on prion disease become available, calibration of more sophisticated models will be possible. In the meanwhile, this is the best we could achieve with the existing experimental evidence. It is interesting to remark how bifurcation analysis, a mathematical tool that is usually considered apt only for qualitative assessments of a model dynamic behavior, could help us derive quantitative results too.
Up to now, epidemiological models of TSEs (see, e.g. Anderson et al., 1996; Stekel et al., 1996) have been based mainly on a phenomenological description of the disease. Laurent's and similar models, because of their simplicity, might be used instead as a building brick in a structured epidemiological model consisting of a collection of di!erent individuals, each being characterized by a set of biochemical and physiological parameters. This would, however, require two crucial steps. First, it would be necessary to go from the local cellular level to the CNS level so as to derive incubation times. This would require the use of spatial models with the problems we described above. Second, a key point in an epidemiological model of this sort would be whether vertical transmission of the disease between a female and its progeny is possible (Butler, 1996) . This occurrence of vertical transmission has recently been evidenced by Donnelly et al. (1997) and Wilesmith et al. (1997) , but whether there is a relationship between the mother's and the progeny's prion protein dynamics remains uncertain. Moreover, we do not know whether the transmission could occur as soon as the cells of the brain are in a pathogenic state or only once the neurological dysfunction has appeared. Despite these uncertainties, there is no doubt, in our opinion, that a model coupling the individual with the population level would be a major step towards 294 E. PORCHER AND M. GATTO testing speci"c hypotheses on the disease spread and building a bridge between laboratory data and the epidemiological evidence.
